US Ends Prezista IP Suit Against Hetero Unit
The federal government on Monday resolved its patent infringement suit in New Jersey against India-based Hetero Drugs Ltd. Unit III over a generic version of HIV drug Prezista....To view the full article, register now.
Already a subscriber? Click here to view full article